Akebia Therapeutics Inc logo

Akebia Therapeutics Inc

NEW
STU:AX9 (USA)  
€ 1.068 +0.016 (+1.52%) Jul 24
At Loss
P/B:
11.96
Market Cap:
€ 287.68M ($ 327.59M)
Enterprise V:
€ 189.56M ($ 215.85M)
Volume:
848.00
Avg Vol (2M):
10.43K
Trade In:
Volume:
848.00
At Loss
Avg Vol (2M):
10.43K

Akebia Therapeutics Inc (STU:AX9) Dividend

Akebia Therapeutics Inc (STU:AX9) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -13%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:AX9 Dividend

Does Akebia Therapeutics Inc (STU:AX9) pay a dividend?

Akebia Therapeutics Inc (STU:AX9) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Akebia Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Akebia Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -13% over the past 3 years.

What are dividend-paying alternatives to Akebia Therapeutics Inc?

For dividend-paying alternatives in Akebia Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.